Geratherm Medical AG Total Assets
Geratherm Medical AG total assets. Based on the latest financial reports, Geratherm Medical AG (GME) holds total assets worth €27.53 Million EUR (≈ $32.19 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Geratherm Medical AG (GME) total market value for the company's overall valuation and market capitalisation.
Total Assets of Geratherm Medical AG (2002–2024)
Total assets of Geratherm Medical AG from 2002 to 2024. This chart illustrates how Geratherm Medical AG's total assets have evolved over time, based on quarterly financial data. See GME share price today for real-time trading data and today's change.
Geratherm Medical AG - Asset Composition Analysis
Geratherm Medical AG Total Assets Breakdown (December 2024)
Geratherm Medical AG total assets breakdown as of December 2024. Geratherm Medical AG's total assets of €27.53 Million consist of 64.9% current assets and 35.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 26.9% |
| Accounts Receivable | €1.33 Million | 4.7% |
| Inventory | €5.90 Million | 20.7% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.61 Million | 5.7% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how Geratherm Medical AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Geratherm Medical AG to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Geratherm Medical AG's current assets represent 64.9% of total assets in 2024, an increase from 62.6% in 2002.
- Cash Position: Cash and equivalents constituted 26.9% of total assets in 2024, down from 43.2% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 2.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 20.7% of total assets.
Geratherm Medical AG Competitors by Total Assets
Key competitors of Geratherm Medical AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩253.22 Billion |
|
Paxman AB
ST:PAX
|
Sweden | Skr487.65 Million |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
Geratherm Medical AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 20.26 | 14.69 | 2.77 |
| Quick Ratio | 14.35 | 7.91 | 1.81 |
| Cash Ratio | 8.69 | 3.22 | 0.00 |
| Working Capital | €16.92 Million | €18.03 Million | €13.59 Million |
Geratherm Medical AG - Advanced Valuation Insights
This section examines the relationship between Geratherm Medical AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.89 |
| Latest Market Cap to Assets Ratio | 0.47 |
| Asset Growth Rate (YoY) | -20.1% |
| Total Assets | €28.54 Million |
| Market Capitalization | $13.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Geratherm Medical AG's assets below their book value (0.47x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Geratherm Medical AG's assets decreased by 20.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Geratherm Medical AG (2002–2024)
The table below shows the annual total assets of Geratherm Medical AG from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €28.54 Million ≈ $33.37 Million |
-20.10% |
| 2023-12-31 | €35.72 Million ≈ $41.76 Million |
-6.93% |
| 2022-12-31 | €38.38 Million ≈ $44.87 Million |
+11.05% |
| 2021-12-31 | €34.56 Million ≈ $40.40 Million |
-3.97% |
| 2020-12-31 | €35.99 Million ≈ $42.08 Million |
+8.19% |
| 2019-12-31 | €33.26 Million ≈ $38.89 Million |
+13.22% |
| 2018-12-31 | €29.38 Million ≈ $34.35 Million |
+3.21% |
| 2017-12-31 | €28.47 Million ≈ $33.28 Million |
+0.23% |
| 2016-12-31 | €28.40 Million ≈ $33.21 Million |
-6.10% |
| 2015-12-31 | €30.25 Million ≈ $35.36 Million |
+6.17% |
| 2014-12-31 | €28.49 Million ≈ $33.31 Million |
-0.73% |
| 2013-12-31 | €28.70 Million ≈ $33.55 Million |
+4.79% |
| 2012-12-31 | €27.38 Million ≈ $32.02 Million |
+11.40% |
| 2011-12-31 | €24.58 Million ≈ $28.74 Million |
-17.95% |
| 2010-12-31 | €29.96 Million ≈ $35.03 Million |
+32.27% |
| 2009-12-31 | €22.65 Million ≈ $26.48 Million |
+50.41% |
| 2008-12-31 | €15.06 Million ≈ $17.61 Million |
-17.10% |
| 2007-12-31 | €18.17 Million ≈ $21.24 Million |
-4.49% |
| 2006-12-31 | €19.02 Million ≈ $22.24 Million |
+2.51% |
| 2005-12-31 | €18.55 Million ≈ $21.69 Million |
-1.70% |
| 2004-12-31 | €18.87 Million ≈ $22.07 Million |
-1.39% |
| 2003-12-31 | €19.14 Million ≈ $22.38 Million |
+1.27% |
| 2002-12-31 | €18.90 Million ≈ $22.10 Million |
-- |
About Geratherm Medical AG
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnosti… Read more